Thus, blocking IL7-R signaling might provide a key therapeutic approach to impact survival of IL-7R expressing memory T cells, improving T cell homeostasis, and controlling inflammation in a state of morbid obesity. The gene discussed is IL7R; the disease is morbid obesity.